Profits and first quarter sales of Swiss drugmaker Novartis have met their 2020 targets following sales at its generics unit continuing through the coronavirus lockdown without disruptions its business. Novartis’ core net income rose to $3.55 billion, up from $2.8… Read More ›
Drugmakers, including Gilead Sciences Inc, Bristol-Myers Squibb Co, and Biogen Inc have hiked their U.S. list prices on more than 50 drugs, according to data analyzed by 3 Axis Advisors, a healthcare research firm. On Tuesday, there were media reports… Read More ›
While Bank of America Corp’s net income applicable to shareholders have risen in comparison to the previous year, they are however lower than analysts’ average expectations. Revenues, net of interest expense, were also lackluster. On Tuesday, Bank of America Corp… Read More ›
Since North America is Toyota’s largest market, an increase in tariffs, especially in its best selling pick-up truck models is likely to boost the cost of its vehicles by at least $3,000. On Friday, Japanese automaker Toyota Motor Corp posted… Read More ›
manageria.biz 